XEMPLAR
DEAD

Serial Number

87898615

Owner

xCella Biosciences, Inc.

Attorney

Jenny Lee

First Use Date

Dec 9, 2018

Filing Date

Apr 28, 2018

Add to watchlist:

No watchlists yet
View on USPTO

XEMPLAR Trademark

Serial Number: 87898615 • Registration: 5801704

XEMPLAR is a trademark filed by xCella Biosciences, Inc. on April 28, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

xCella Biosciences, Inc. (3 trademarks)

1490 O'Brien Dr, Suite C
Menlo Park, CA 94025

Entity Type: 03

Trademark Details

Filing Date

April 28, 2018

Registration Date

July 9, 2019

First Use Anywhere

December 9, 2018

First Use in Commerce

December 9, 2018

Published for Opposition

October 2, 2018

Cancellation Date

January 23, 2026

Goods & Services

Scientific, biological, and medical research; consulting services in the fields of biotechnology, pharmaceutical research and development, and design and development of proteins, enzymes, biologics, and drug formulations; scientific and technological services, namely, research in the fields of chemistry and molecular biology, namely, protein and biologics detection, characterization, analysis and testing; research and development services in connection with the design, synthesis and assembly of nucleic acids, peptides, proteins, cells, nucleic acid arrays, peptide arrays, and protein arrays

Chemical, biochemical, and biological preparations, namely, antibodies and fragments of antibodies for use in the development of reagents for industrial and scientific use; biochemical and biological preparations, namely, antibodies and fragments of antibodies for scientific or research use

Pharmaceutical preparations and substances for the treatment of cancer, inflammatory diseases, and other conditions which can be treated or ameliorated by antibodies binding to, or activation or blocking of, a target antigen; antibodies and fragments of antibodies for use in pharmaceutical preparations

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 23, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 9, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 7, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 6, 2019 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 2019 CRFA
ASSIGNED TO LIE
May 16, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 9, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 20, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 20, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Mar 20, 2019 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 7, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 7, 2019 AITU
USE AMENDMENT FILED
Jan 11, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 11, 2019 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 27, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 2, 2018 NPUB
PUBLISHED FOR OPPOSITION
Oct 2, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 12, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2018 CNSA
ASSIGNED TO EXAMINER
Aug 20, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 8, 2018 NWOS
NEW APPLICATION ENTERED
May 2, 2018 NWAP